Skip to content
★ Sign in to follow
SB

Steve B. Warnecke

Executive
Chairman & CEO
Evolutionary Genomics, Inc.Bone Biologics CorpEvolving Systems Inc
Total declarations
20
Companies
3
▲ Purchases (5 ops.)
€101k
▼ Sales (0 ops.)
—

Latest filing published 25 May 2022 for Evolutionary Genomics, INC., €34k.

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
5
Positive at T+90
80%
Median T+90
+39.3%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 12 Dec 2008 · 6540 days ago · €11k
    +281.6%
    Entry US$1.58 · Close at T+365 US$6.03
  • Filed 10 Dec 2008 · 6542 days ago · €603
    +258.9%
    Entry US$1.68 · Close at T+365 US$6.03
  • Filed 05 Dec 2007 · 6913 days ago · €71k
    -64.3%
    Entry US$4.54 · Close at T+365 US$1.62

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Steve B. Warnecke: trading record in brief

This profile gathers the share dealings of Steve B. Warnecke across 3 companies, led by Evolving Systems Inc, Evolutionary Genomics, Inc. and Bone Biologics Corp. Between 4 December 2007 and 23 May 2022, the trades on record add up to 20 filings.

Purchases make up the whole of the open-market record (5 purchases, €101k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 8 share grants and 1 option exercise.

In size, the median ticket on the buying side is €11k. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 80% of cases, with a median move of +39.3%. These figures describe past trades and do not predict future prices.

The newest entry dates from 25 May 2022: a share grant of €34k, in Evolutionary Genomics, Inc. The clock since the last published purchase (12 December 2008) now reads 6,540 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Steve B. Warnecke

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total

19 of 19 declarations